Evidence map›Paper›PMID 19398647›Full record

ArticleAntimicrobial agents and chemotherapy2009

Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006.

L F Mataseje, N Neumann, B Crago, P Baudry, G G Zhanel, M Louie, M R Mulvey, ARO Water Study Group

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Multidrug-ResistantPathogens (Basel, Switzerland) · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. The Canadian Institutes of Health Research response to antimicrobial resistance.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2015
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antimicrobial-resistant Escherichia coli in public beach waters in Quebec.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2012
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

L F MatasejeNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
N Neumann
B Crago
P Baudry
G G Zhanel
M Louie
M R Mulvey
ARO Water Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A total of 142 cefoxitin-resistant Escherichia coli isolates from water sources were collected across Canada. Multidrug resistance was observed in 65/142 (45.8%) isolates. The bla(CMY-2) gene was identified in 110/142 (77.5%) isolates. Sequencing of the chromosomal ampC promoter region showed mutations from the wild type, previously shown to hyperproduce AmpC. CMY-2-producing plasmids predominantly belonged to replicon groups I1-Igamma, A/C, and K/B. The majority of the E. coli isolates belonged to the nonvirulent phylogenetic groups A and B1.

Indexed as

Bathing BeachesWater MicrobiologyAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCanadaCefoxitinDrug Resistance, BacterialEscherichia coliMutationAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase CMY-2beta-LactamasesCefoxitin

Identifiers

PMID19398647
PMCPMC2704656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.